PDCD1 and gastric cancer: The latest evidence has demonstrated that blockade of programmed cell death protein 1 (PD-1) is non-inferior to chemotherapy (Shitara et al., 2020a), and the combination of PD-1 inhibitor with chemotherapy shows superior survival versus chemotherapy alone in patients with advanced GC (Janjigian et al., 2021).